Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
NEW BRUNSWICK, N.J., Jan. 27, 2022 /PRNewswire/ -- Johnson and Johnson Pharmaceutical Research and Development, LLC (NJ)(NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-citis-2022-virtual-healthcare-conference-301470256.html
SOURCE Johnson & Johnson
Company Codes: NYSE:JNJ